Lymphatic System Neoplasm Clinical Trials

59 recruitingLast updated: May 29, 2026

There are 59 actively recruiting lymphatic system neoplasm clinical trials across 3 countries. Studies span Not Applicable, Phase 2, Phase 1, Early Phase 1, Phase 3. Top locations include Rochester, Minnesota, United States, Jacksonville, Florida, United States, Seattle, Washington, United States. Updated daily from ClinicalTrials.gov.


Lymphatic System Neoplasm Trials at a Glance

59 actively recruiting trials for lymphatic system neoplasm are listed on ClinicalTrialsFinder across 6 cities in 3 countries. The largest study group is Not Applicable with 27 trials, with the heaviest enrollment activity in Rochester, Jacksonville, and Seattle. Lead sponsors running lymphatic system neoplasm studies include Mayo Clinic, City of Hope Medical Center, and Fred Hutchinson Cancer Center.

Browse lymphatic system neoplasm trials by phase

Treatments under study

About Lymphatic System Neoplasm Clinical Trials

Looking for clinical trials for Lymphatic System Neoplasm? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Lymphatic System Neoplasm trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Lymphatic System Neoplasm clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 59 trials

Recruiting

Investigating Memory and Physical Activity After Cancer Treatment in Survivors of Adolescent and Young Adult Cancers

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
Mayo Clinic100 enrolled1 locationNCT06880861
Recruiting
Not Applicable

Acupressure for the Reduction of Anxiety in Patients Receiving Cancer-Directed Therapy

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
Mayo Clinic78 enrolled1 locationNCT06723041
Recruiting
Phase 2

Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies

Hematopoietic and Lymphatic System NeoplasmMetastatic Malignant Solid NeoplasmDepression+1 more
University of Washington18 enrolled1 locationNCT07336238
Recruiting
Not Applicable

Dental Cleaning to Prevent Chronic Graft-Versus-Host Disease

Acute Graft Versus Host DiseaseHematopoietic and Lymphatic System NeoplasmChronic Graft Versus Host Disease
Fred Hutchinson Cancer Center45 enrolled1 locationNCT07535008
Recruiting
Phase 2

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

Breast CarcinomaUrothelial CarcinomaOvarian Carcinoma+26 more
Mayo Clinic27 enrolled1 locationNCT07285044
Recruiting
Phase 1Phase 2

Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness

Hematopoietic and Lymphatic System NeoplasmMetastatic Malignant Solid NeoplasmStage IV Colorectal Cancer AJCC v8+4 more
National Cancer Institute (NCI)58 enrolled23 locationsNCT05691491
Recruiting
Not Applicable

A Culturally Informed Patient Navigation Program (CFPN) to Reduce Delays Between Diagnosis and Treatment in American Indian and Alaska Native Cancer Patients Living in Rural California

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
University of Southern California71 enrolled2 locationsNCT07332312
Recruiting
Early Phase 1

L-Theanine to Support Relaxation and Mood for Cancer Patients in Surveillance

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
City of Hope Medical Center50 enrolled4 locationsNCT07220447
Recruiting
Not Applicable

Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
NRG Oncology600 enrolled34 locationsNCT06279013
Recruiting

Optimizing Health Related Quality of Life Measurement in Adolescent and Young Adult Oncology

Malignant Solid NeoplasmLymphatic System NeoplasmHematopoietic Neoplasms
Wake Forest University Health Sciences3,000 enrolled1 locationNCT06897137
Recruiting
Not Applicable

Sustained Oral Fiber Supplementation for Patients Undergoing Donor Stem Cell Transplantation for Hematological Malignancies

Hematopoietic and Lymphatic System Neoplasm
Fred Hutchinson Cancer Center40 enrolled1 locationNCT04829136
Recruiting
Not Applicable

Community-Based Exercise and Nutrition Training and Education Program for Cancer Survivors

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
Roswell Park Cancer Institute150 enrolled1 locationNCT06565260
Recruiting
Not Applicable

Evaluating a Mobile Health Application Intervention for Caregiver Instruction in Manual Therapy for Chemotherapy-Induced Peripheral Neuropathy

Hematopoietic and Lymphatic System NeoplasmMalignant Solid NeoplasmChemotherapy Induced Peripheral Neuropathy
Mayo Clinic300 enrolled1 locationNCT06945380
Recruiting
Not Applicable

Pre-Operative Guided Meditation to Reduce Pre-Operative Anxiety in Patients Undergoing Cancer-Directed Surgery

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
Ohio State University Comprehensive Cancer Center300 enrolled1 locationNCT06949943
Recruiting
Phase 3

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
Children's Oncology Group60 enrolled193 locationsNCT06513962
Recruiting
Not Applicable

Telephone-Based Coaching Sessions (TAC) to Improve Advance Care Planning Participation in Advanced Cancer Patients and Their Support Person

Hematopoietic and Lymphatic System NeoplasmAdvanced Malignant Solid Neoplasm
Fred Hutchinson Cancer Center80 enrolled2 locationsNCT07141407
Recruiting
Not Applicable

Patient Navigation and the Planning Advance Care Together Website to Improve Goals of Care Conversations in Hematopoietic Cell Transplant Survivors, IMPACT-HCT Trial

Hematopoietic and Lymphatic System Neoplasm
Fred Hutchinson Cancer Center40 enrolled1 locationNCT07052630
Recruiting
Not Applicable

Virtual Reality Viewing of Unaltered Streetscape Versus Digitally Manipulated Opposite Streetscape to Assess Psychosocial Response in Participants

Hematopoietic and Lymphatic System NeoplasmMalignant Solid NeoplasmPsychiatric Disorder
Ohio State University Comprehensive Cancer Center32 enrolled1 locationNCT07216534
Recruiting
Phase 1

Biomarker-Guided Ruxolitinib for the Prevention of Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation

Hematopoietic and Lymphatic System Neoplasm
City of Hope Medical Center42 enrolled1 locationNCT07025538
Recruiting

Wearable Activity Tracking to Curb Hospitalizations

Malignant Solid NeoplasmHematopoietic NeoplasmLymphatic System Neoplasm
University of California, San Francisco260 enrolled1 locationNCT06587100